FDA Warning Letter
Renewal Supplements received a "Warning Letter" from the FDA dated August 25, 2020 for claims made on the website established that the product is intended for use as a drug.
Our product is not intended for use as a drug and we understand FDA's concerns and acknowledged the drug claims were made on our website and have been removed. We are committed to taking all actions necessary to ensure we are in compliance.
We have hired a regulatory consultant to review our website, and labeling, to ensure corrective actions have been made and regulatory compliance has been met.
We recognize and take seriously the significance of the observations in the Warning Letter, and are committed to taking all actions necessary to ensure our systems are in compliance with FDA requirements.